Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Immunoglobulin Light-chain Amyloidosis 3Multiple Myeloma 1

Interventions

daratumumab 6Dexamethasone 6pomalidomide 4Bortezomib 4Focal Adhesion Protein-Tyrosine Kinases 3venetoclax 2Specimen Handling 2Cyclophosphamide 2Calcium Dobesilate 2talquetamab 1ixazomib 1idecabtagene vicleucel 1dexamethasone acetate 1dexamethasone 21-phosphate 1darlin protein, Dictyostelium 1belantamab mafodotin 1auricularum 1X-Rays 1Tissue Banks 1Stem Cell Transplantation 1Spectrometry, Fluorescence 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Phantoms, Imaging 1Melphalan 1Magnetic Resonance Spectroscopy 1Hyaluronoglucosaminidase 1Biopsy 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Immunoglobulin Light-chain Amyloidosis × Focal Adhesion Protein-Tyrosine Kinases × Clear all
NCT07079423 2025-07-23

Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis

Peking Union Medical College Hospital

Phase 2 Recruiting
35 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06935162 2025-05-25

Teclistamab in Previously Treated AL Amyloidosis

Peking Union Medical College Hospital

Phase 2 Recruiting
30 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06699394 2025-04-24

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

Peking University People's Hospital

Phase NA Recruiting
20 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡